S&P 500 · SPY
769.36
▼ -2.95 (-0.38%)
DOW JONES · DIA
522.73
▼ -1.95 (-0.37%)
NASDAQ · QQQ
715.34
▼ -10.27 (-1.42%)
GOLD · GLD
$368.57
▼ -4.94 (-1.32%)
OIL (WTI) · USO
$168.19
▲ +1.62 (+0.97%)
BITCOIN
$78,912.37
▼ -2,347.45 (-2.89%)
--:--:--
NYSE · Live ET

West Pharma earnings show it's more than a GLP-1 play. Why we see more upside

Since CNBC highlighted the stock's attractive valuation in August, shares have gained around 20%. Why we expect more upside ahead.

Summary from the CNBC news feed. Copyright belongs to CNBC.

Read full story at CNBC ↗

Opens in a new tab, so Investz stays open.

ShareEmailXLinkedInFacebookRedditWhatsApp

Related on Investz

More headlines

All news
CNBCAmazon posts negative free cash flow of $42.4 billion, holds 2026 capex unchangedCNBCIntel stock plunges 16% as chipmaker blames PC slowdown for weak guidanceMarketWatchMy wife cried when I found out she had only $80,000 in her 401(k). I have $2.2 million. Am I wrong to be shocked?MarketWatchThe S&P 500 isn’t the big winner you may think it isMarketWatchSandisk sees revenue nearly quintuple — and its stock is heading higherCNBCReddit shares sink on weak sales guidance and plans login requirement test as Google search traffic shrinks

Headlines and summaries come from publishers’ public news feeds and are shown with attribution and a link to the original. Investz does not write or endorse them and they are not investment advice. Disclosures.